Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

Date Posted: 

Tuesday, September 26, 2017

The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of digital mammography for breast cancer screening, is now open for enrollment. TMIST researchers are enrolling healthy women ages 45 to 74 who are already planning to get routine mammograms. By taking part in TMIST, the 165,000 planned participants will provide critical information that will help researchers learn how to most effectively screen women for breast cancer and help women make informed decisions about the screening tests in the future.

Read the NCI Press Release

For more information view the full article at: 

NCI Press Release